API Holdings Releases Full Pledge on 49.93% Stake in Thyrocare Technologies
Thyrocare Technologies Ltd · Encumbered Shares - Invocation / Release · 09 Sept 2026, 5:52 pm
API Holdings Releases Full Pledge on 49.93% Stake in Thyrocare Technologies Docon Technologies fully released its pledge on 7,94,69,696 equity shares of Thyrocare Technologies, representing 49.93% of total share capital, on 17th Aug'26. This follows API Holdings’ complete redemption and repayment of INR 10,500 mn in outstanding NCDs on 14th Aug'26. Consequently, no encumbrance remains on the promoter holding of 8,12,00,000 shares (51.02%). Additionally, Docon amalgamated into parent API Holdings effective 3rd Sep'26 post-NCLT approval, vesting all assets and liabilities into API Holdings as the successor entity.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. · 06 Nov 2026
- Please find the enclosed intimation. · 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 · 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement · 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 · 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 · 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 · 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 · 29 Oct 2026
